CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pronutria Biosciences Inc., a biotechnology company pioneering first-in-class medicines for serious conditions linked to amino acid imbalances, announced today that Robert Connelly, President and Chief Executive Officer, will present a company overview at the Cowen and Company 36th Annual Health Care Conference in Boston, MA.
